U.S. drugmaker Allergan Inc rejected Valeant Pharmaceuticals International Inc's unsolicited takeover offer, saying it substantially undervalued the company, Reuters reported.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
18 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
19 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
19 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
19 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
19 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
19 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
21 hours ago · 3 mins read
